The Director of the program is Olivier Hermine. The new governance includes 6 bureaus
The Executive Committee (EC) is composed of 3 members:
- Olivier Hermine (Chair)
- Caroline Le Van Kim
- Laurent Gouya
Role: As the decision-making body, the EC define and supervise the general strategy of the GR-Ex project and oversee the budget. EC meetings will be held twice a year, each March with the Scientific Advisory Board and each September. Meetings can also be called upon by special request of any of the EC or Scientific Committee members in order to respond to a clearly defined need.
The Clinical Committee (CC), currently chaired by Pierre Buffet, is composed of 3 members:
- Pierre Buffet
- Sandra Manceau
- Joël Veiga
Role: the CC is coordinating all the studies linked to the clinical protocol which promoter is the Imagine Institute.
The Scientific Committee (SC), currently chaired by Eric Soler, is comprised of 10 GR-Ex members appointed by the EC. Their respective expertise include:
- Epigenetic: Eric Soler (Chairman)
- Erythropoiesis – metabolism : Sandrina Kinet
- Translational Biology: Lydie da Costa
- Red Cells: Yves Colin Aronovicz
- Epidemiology: Brigitte Ranque
- Bioinformatic: Catherine Etchebest
- Iron metabolism: Sophie Vaulont
- Hemopathies: Mariane de Montalembert
- Malaria: Catherine Lavazec
- Blood transfusion: Thierry Peyrard
Role: The SC will advise on new projects, give direction to the EC, organize workshops and write scientific reports.
The Education Committee (EdC) is comprised of 3 GR-Ex members:
- Anaïs Merckx
- Stéphane Egée
- Wassim El Nemer
Role: The EdC will develop both training courses and lab workshops, eventually elaborate and/or sponsor Master programs.
The Technology Transfer Advisory Committee (TTAC) is comprised of two members:
- Olivier Hermine
- Joël Veiga
Role: The TTAC develop collaborations with other scientific institutions, both in France and abroad. It will collaborate with the French government organization focused on promoting industrial relations (ERGANEO) to develop partnerships with the private sector and promote core facility sharing amongst GR-Ex partners.
The Scientific Advisory Board (SAB), currently chaired by Mohandas Narla, is internationally renowned and is comprised of 5 members with expertise in diverse aspects of the red cell field:
- Mohandas Narla, New York Blood Center, USA
- Catherine Lacombe, Paris Descartes University, Cochin Institute, France
- Mario Cazzola, University of Pavia, Italy
- Patrick G. Gallagher, Yale University, USA
- Russell E. Ware, Cincinnati Children’s Hospital Medical Center, USA
Role: The SAB spearhead the global review of the consortium’s activities, advise on the integration of new research partners, and evaluate projects from the internal call for proposals.